Prostate Cancer News & Features
Black men are twice as likely to be diagnosed with, or die from, prostate cancer in their lifetime compared to white men.
Prostate cancer has five distinct types, with different ways to determine which type of tumor a patient has.
A sensor chip, able to pick up on differences in glycoprotein molecules, can improve accuracy and efficiency of prostate cancer diagnosis.
Patients with prostate cancer are now more likely to receive medical care matched to risk level.
A recent study indicates a high rate of clinical upgrading at prostatectomy, based on over ten thousand patients reviewed.
Prostate Cancer Videos
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Likelihood of lung cancer screening update
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- Activated T cell therapy developed for advanced melanoma
- Avocados may hold the answer to beating leukemia
- Cardio-oncology services may improve patient care if more widely available
- Managing oral oncology/hematology treatments in your practice
- Universal health literacy precautions recommended to assist patient understanding
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Online registry improves clinical research study participation
- Five-day aprepitant versus fosaprepitant in patients receiving cisplatin
- Black men twice as likely to die from prostate cancer compared to white men
- Research findings differentiate prostate cancer tumors into five different types
- Robotic IVC thrombectomy appears successful in patients with kidney cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|